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  The serum levels g／f Cefgulodin and Cefotiam，． ’new semisynthetic gepharosporines， in uremic
patients were determined during blood purification．
  Cefsulodin was given in a single intravenous dose ef O．5 g to uremic patients before blood puri一
最cation， Serum levels were l 2．3－32．3 mcg／ml aftcr 30皿inutes，7．2－17．6 mcg／ml af㌔er 2 hours and
3．4一一8，9 mcg／ml after・ blooq purification． The half－life ．of Cgfsulodin． during． hcmodiglysis， hemo－
diafiltration and hemofiltration was 3．05 hours， 1．37 hours and 2．．28 ．hpurs icespectively．
  ．Ce． itteiam was given by the same methQd as Cefsulodih to uremic p4tiepts befofe． b．IQod Purifi一．’
・孕ゆ1．．1Ser・m lξ・・1卵や・e．23・249・7 m・9／ml・ft・・30．血i・・t…13・4－20・o卸9／ml．晦2h・u・s・h4．
5．9－10．0 mcg／ml after blood purification． Thc half－life of Cefotiam during’hem6dialysis， hemodia一’
lilt・ati・n．鱒h・血・丘1tr嘩i・n．W・・1・85 h・urs and L23 hq…and 2・13 hqu・…e・pecti・qly・
  rl］hese tsyg new antibiotics were well dialysed or filtrated by ．blood putificatiQh．
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Table 1． Patients undergoing blood purification


















































CGN ： Chronic gromerulonephritis PCK ： Polycystic kidney
－HD ： Hemodialysis HF ： Hemofiltration HDF 1 Hemo－diafilation
Table 2． Serum levels of cefsulodin in uremic patients
（mcg／ml）
Case























































































































Table 3．Serum levels of cefotiam in uremic patients
                      （mcg／ml）
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Case



















































nd ： not detectable
験中は，他の抗菌剤は使用していない．












 T log 2 n一 IVTXX log Y一 （xx） 一（X log Y）
liM＝＝ff， M＝一一XX2一（XX）2
tev， ｛・血中灘糊時間
    x：時間 y：血中濃度
    N：血中濃度測定回数
成 績
























   1    2    3    4    5    6
        Time （hovr）
Fig． 1． Changes of cefsulodin in serum
 cefsulodinの血液浄化時の血中濃度半減期時は，
























   1   2    3    4   5   6
       Time （hour）
Fig． 2． Changes of cefotian in serum
 cefotiamの血中濃度半減時間は， HD 1．85時間，
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